Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000154050 | SCV000051133 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000040621 | SCV000064312 | benign | not specified | 2015-03-21 | criteria provided, single submitter | clinical testing | p.Thr23012Met in exon 275 of TTN: This variant is not expected to have clinical significance because it has been identified in 2.1% (178/8516) of East Asian chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs56372592). |
Eurofins Ntd Llc |
RCV000040621 | SCV000203688 | benign | not specified | 2013-11-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000040621 | SCV000236681 | benign | not specified | 2014-08-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001086679 | SCV000286839 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000251684 | SCV000318224 | likely benign | Cardiovascular phenotype | 2013-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000768921 | SCV000900294 | benign | Cardiomyopathy | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001133867 | SCV001293581 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-06-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001133868 | SCV001293582 | benign | Tibial muscular dystrophy | 2017-06-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001133869 | SCV001293583 | benign | Dilated cardiomyopathy 1G | 2017-06-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001135363 | SCV001295140 | benign | Early-onset myopathy with fatal cardiomyopathy | 2017-06-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001135364 | SCV001295141 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2017-06-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Genome- |
RCV001133867 | SCV002100182 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001135364 | SCV002100183 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001135363 | SCV002100184 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001133868 | SCV002100185 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040621 | SCV003801247 | likely benign | not specified | 2023-01-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000154050 | SCV005878314 | benign | not provided | 2024-07-25 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000154050 | SCV001743596 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000154050 | SCV001799479 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040621 | SCV001924451 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000040621 | SCV001926729 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000040621 | SCV001957943 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000154050 | SCV001967619 | likely benign | not provided | no assertion criteria provided | clinical testing |